And it’s not Scanadu. Scanadu may be the ‘tricorder’ of the future, but telehealth companies are looking for a here-and-now medical monitoring device that can take the place of multiple health monitors and provide clinically accurate readings. This Editor noted Swiss-American company SensoGRAM‘s press release at last year’s mHealth Summit, but this year, in a large booth near the front of the now HIMSS Connected Health Conference expo floor, they were demonstrating production versions of SensoSCAN. The fingertip sensor, similar to a pulse oximeter, measures blood pressure, respiration rate, heart rate, and O2 saturation, plus activity levels and fall detection, and sends the information to your smartphone via app. It is being sold DTC on their website ‘for informational purposes only’ for $349.99. According to chief administrative officer Lisa D’Auria (her hand at left), they are also in clinical trials for FDA 510(k) clearance, hoping to have within less than a year, and are in progress with CE Marking. Unusually, it is manufactured in the US. Release.